I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Objective To find a safe dose of metarrestin and to see if this dose shrinks tumors. Eligibility Adults age 18 and older with pancreatic cancer, breast cancer, or a solid tumor that has not been cured by standard therapies.
blood tests
renal function test
ct scan
platelet count
metarrestin
- 0 views
- 16 Feb, 2024
- 1 location